Similar articles

• Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.

  Endogenous Hormones and Prostate Cancer Collaborative Group; Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous Hormones and Prostate Cancer Collaborative Group, et al. J Natl Cancer Inst. 2008 Feb 6;100(3):170-83. doi: 10.1093/jnci/djm323. Epub 2008 Jan 29. J Natl Cancer Inst. 2008. PMID: 18230794 Free PMC article.
• Interrelationships of circulating maternal steroid concentrations in third trimester pregnancies. II. C18 and C19 steroids: estradiol, estriol, dehydroepiandrosterone, dehydroepiandrosterone sulfate, delta 5-androstenediol, delta 4-androstenedione, testosterone, and dihydrotestosterone.

  Buster JE, Chang RJ, Preston DL, Elashoff RM, Cousins LM, Abraham GE, Hobel CJ, Marshall JR. Buster JE, et al. J Clin Endocrinol Metab. 1979 Jan;48(1):139-42. doi: 10.1210/jcem-48-1-139. J Clin Endocrinol Metab. 1979. PMID: 154525
• Androgenic hormones and prostate cancer risk: status and prospects.

  Gann PH. Gann PH. IARC Sci Publ. 2002;156:283-8. IARC Sci Publ. 2002. PMID: 12484188 Review. No abstract available.
• Prediagnostic serum hormones and the risk of prostate cancer.

  Nomura A, Heilbrun LK, Stemmermann GN, Judd HL. Nomura A, et al. Cancer Res. 1988 Jun 15;48(12):3515-7. Cancer Res. 1988. PMID: 3370644
• 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.

  Rittmaster RS. Rittmaster RS. Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):389-402. doi: 10.1016/j.beem.2008.01.016. Best Pract Res Clin Endocrinol Metab. 2008. PMID: 18471794 Review.